US Patent Issued to NINGBO T-MAXIMUM BIOPHARMACEUTICALS on Nov. 3 for "Modified immune effector cell and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,243, issued on Nov. 3, was assigned to NINGBO T-MAXIMUM BIOPHARMACEUTICALS Co. LTD. (Ningbo, China).

"Modified immune effector cell and preparation method therefor" was invented by Xiaoyun Shang (Suzhou, China), Haijuan Jiang (Suzhou, China), Dan Wang (Suzhou, China), Hui Shen (Suzhou, China), Li Ma (Suzhou, China), Yu Xin (Suzhou, China), Fanli Xu (Suzhou, China), Jialu Li (Suzhou, China), Shaowen Ma (Suzhou, China) and Dan Zhao (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a modified immune effector cell, wherein compared with the expression and/or activity of the corresponding gene in a corresponding unmodified cell, th...